Dr. Dhanalakshmi Sivanandhan completed B.Sc. Zoology/Botany during 1992-1995. She has received her Ph.D in Life Sciences (Cancer Research) from Jawaharlal Nehru University, New Delhi, India. She is the Chief Scientific Officer of Theralndx Lifesciences, Bangalore, meant for drug discovery and development. Prior to this, she was heading the Discovery Biology at Jubilant Therapeutics, a pharmaceutical company. She executed 25 oncology discovery projects delivering three pre-clinical candidates and out-licensed one of the in-house projects to a US based Biotech. She has completed two post-doctoral trainings, at National Cancer Center, Tokyo, Japan and at University of Colorado Health Sciences Center, Denver, USA. She has over 30 publications in peer-reviewed international journals and authored several patents.